Showing results (361-370 of 427) with videos related to

Sort By:
Pageof 43
Human Molecular Genetics|June 27, 2023
Metabolic liver cancer: associations of rare and common germline variants in one-carbon metabolism and DNA methylation genesSamuel O Antwi, Michael Heckman, Launia White, et al.
The American Journal of Gastroenterology|July 17, 2024
The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and EndpointsElliot B Tapper, David Goldberg, Neehar D Parikh, et al.
Hepatology (Baltimore, Md.)|August 3, 2023
Osteopontin characterizes bile duct-associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitisKevin De Muynck, Lander Heyerick, Federico F De Ponti, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 14, 2019
Development and Validation of Hepamet Fibrosis Scoring System-A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced FibrosisJavier Ampuero, Raluca Pais, Rocío Aller, et al.
The American Journal of Pathology|July 28, 2019
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic CholangiocarcinomaChiara Raggi, Karim Fiaccadori, Mirella Pastore, et al.
Nature Reviews. Gastroenterology & Hepatology|April 21, 2016
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)Jesus M Banales, Vincenzo Cardinale, Guido Carpino, et al.
Frontiers in Medicine|July 12, 2021
Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLDVanda Marques, Marta B Afonso, Nina Bierig, et al.
Hepatology (Baltimore, Md.)|May 31, 2017
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinomaAnder Arbelaiz, Mikel Azkargorta, Marcin Krawczyk, et al.
Hepatology (Baltimore, Md.)|November 15, 2021
Quality measures in HCC care by the Practice Metrics Committee of the American Association for the Study of Liver DiseasesSumeet K Asrani, Marwan S Ghabril, Alexander Kuo, et al.
Hepatology (Baltimore, Md.)|July 28, 2023
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)Mazen Noureddin, Emily Truong, Rebeca Mayo, et al.
Pageof 43